Intravenous thrombolysis (IVT) with a tissue-type plasminogen activator (tPA) named alteplase has been the only and preferred treatment for 25 years; it is currently the only FDA and EU approved medical treatment for patients with acute ischemic stroke (AIS) [23]. The gene discussed is PLAT; the disease is androgen insensitivity syndrome.